Drug name - Elyxyb
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10722456 | BDSI | Oral composition of celecoxib for treatment of pain |
May, 2036
(13 years from now) | |
| US10799517 | BDSI | Oral composition of celecoxib for treatment of pain |
May, 2036
(13 years from now) | |
| US9949990 | BDSI | Oral composition of celecoxib for treatment of pain |
May, 2036
(13 years from now) | |
| US9795620 | BDSI | Oral composition of celecoxib for treatment of pain |
May, 2036
(13 years from now) | |
| US9572819 | BDSI | Oral composition of celecoxib for treatment of pain |
May, 2036
(13 years from now) | |
| US10376527 | BDSI | Oral composition of celecoxib for treatment of pain |
May, 2036
(13 years from now) | |
Drugs and Companies using CELECOXIB ingredient
Treatment: Acute treatment of migraine with or without aura in adults
Dosage: SOLUTION;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 25MG/ML | SOLUTION;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.